Quantcast
Home / Practice Areas / Business and Civil Practice / J&J must pay $257M over Risperdal marketing

J&J must pay $257M over Risperdal marketing

Johnson & Johnson lost a $257.7 million jury verdict in Louisiana for making misleading claims about the safety of the company's Risperdal antipsychotic drug.